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Serum samples were obtained from 252 horses in the
State of Yucatan, Mexico, from July to October 2002.
Antibodies to West Nile virus were detected by epitope-
blocking enzyme-linked immunosorbent assays in three
(1.2%) horses and confirmed by plaque reduction neutral-
ization test. We report the first West Nile virus activity in the
State of Yucatan.
W
est Nile virus (WNV) is a member of the Japanese
encephalitis virus complex within the genus
Flavivirus, family Flaviviridae (1). The virus is transmit-
ted in natural cycles mainly between mosquitoes and birds,
with humans and horses serving as incidental hosts (2).
WNV was first isolated in 1937 from the blood of a febrile
adult human in the West Nile District of Uganda (3). This
virus has since been reported in Africa, the Middle East,
Asia, southern Europe, Australia, and, more recently,
North America (4,5). The initial outbreak of WNV in
North America was recognized in New York City in
August 1999, with deaths reported in humans, horses, and
numerous species of birds. Since then, the geographic dis-
tribution of WNV in North America has greatly increased.
WNV activity has now been reported in 44 states and the
District of Columbia in the United States and in 5 of the 10
Canadian provinces (6,7). 
In response to the incursion and rapid spread of WNV
in North America, we established equine and avian infec-
tion surveillance in Yucatan State, Mexico, in March 2000.
Yucatan State is a likely point of incursion of this virus into
Latin America because this area is a principal landfall for
many species of birds that migrate from the northeastern
and midwestern United States (8). 
To determine whether WNV had already reached this
part of Mexico, we obtained blood samples from 252
domestic horses in 14 study sites from July to October
2002 (Table 1). The age distribution of the horses was 3
months to 25 years, and the mean age was 8.2 years. One
hundred and fifty-one horses were male, and 101 were
female. All study sites were on privately owned ranches,
where the horses were primarily used to perform heavy
labor and herd cattle. According to the owners, none of the
horses had ever been outside the State of Yucatan.
Furthermore, none of the horses had been vaccinated
against WNV.
The climate and topography of the study sites are simi-
lar. The climate can be described as tropical. The average
annual rainfall in each study site ranges from 600 to 1,100
mm, and the average annual temperature is 26°C. The
average elevation is approximately 17 m. 
All serum samples were screened for antibodies to fla-
viviruses by hemagglutination inhibition (HI) assays and
epitope-blocking enzyme-linked immunosorbent assays
(ELISAs) at the Universidad Autonoma de Yucatan in
Merida. HI assays were performed by using Saint Louis
encephalitis virus (SLEV) antigen as previously described
(9). This antigen recognizes cross-reactive HI antibodies to
WNVand to other flaviviruses. To preclude nonspecific HI
reactions, samples were treated with kaolin, then adsorbed
with goose erythrocytes, according to standard methods
(9). Epitope-blocking ELISAs were performed by using
the flavivirus group-reactive monoclonal antibody (MAb),
6B6C-1, or the WNV-specific MAb, 3.1112G as previous-
ly described (10). The ability of the Mexican horse serum
samples to block the binding of MAbs to WNV antigen
was compared to the blocking ability of horse serum with-
out antibody to WNV (Vector Laboratories, Burlingame,
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Table 1. Study sites and numbers of horses sampled per site, 
State of Yucatan, Mexico 
Study site 
Global Positioning  
System location 
No. (%) of  
horses bled 
Acanceh  20° 48' 46" N, 89° 27' 14" W  8 (3.2) 
Caucel  21° 00' 53" N, 89° 42' 25" W  1 (0.4) 
Hobonil  20° 00' 54" N, 89° 01' 15" W  26 (10.3) 
Hunucma  21° 00' 55" N, 89° 52' 28" W  7 (2.8) 
Mani  20° 23' 11" N, 89° 23' 37" W  1 (0.4) 
Merida  20° 58' 04" N, 89° 37' 18" W  63 (25.0) 
Molas  20° 48' 57" N, 89° 37' 55" W  5 (2.0) 
Progreso  21° 17' 04" N, 89° 39' 48" W  31 (12.3) 
Sierra Papacal  21° 07' 16" N, 89° 43' 41" W  14 (5.6) 
Timucuy  20° 48' 34" N, 89° 30' 51" W  5 (2.0) 
Tixkokob  21° 00' 08" N, 89° 23' 37" W  15 (6.0) 
Tizimin  21° 08' 32" N, 88° 09' 03" W  49 (19.4) 
Uman  20° 49' 38" N, 89° 41' 08" W  26 (10.3) 
Xbec  21° 14' 54" N, 88° 49' 29" W  1 (0.4) 
Total    252 (100) CA). Data were expressed as relative percentages, and
inhibition values >30% were considered to indicate viral
antibodies. Recent studies in this laboratory have shown
that epitope-blocking ELISA provides a rapid and reliable
serologic technique for the detection of WNVantibodies in
various vertebrate species, including horses (10,11).
Six horses had evidence of flavivirus infection by HI
assay or ELISA (Table 2). Serum samples from three of
these horses (H-117, H-126, and H-252) were positive in
the ELISA that used the WNV-specific MAb. H-117 (7-
year-old stallion) and H-126 (2-year-old stallion) were
both sampled at the Tizimin study site. Neither horse
showed signs of illness at the time of serum collection or
during the 7 months that followed. Furthermore, neither
horse had a history of WNV-like illness. H-252 was a 3-
year-old stallion from Caucel that exhibited neurologic and
muscular symptoms at the time of sampling; it was eutha-
nized several hours later. We were not able to obtain tissue
specimens from this horse postmortem. Of the 252 horses
sampled, the only other horse to exhibit signs of clinical
illness was H-60, which had signs consistent with gastroin-
testinal illness.
Serum samples positive for flavivirus antibodies by HI
assay or ELISA were tested by plaque reduction neutral-
ization assay (PRNT) to identify the infecting virus.
PRNTs were conducted in the BSL-3 facilities at Colorado
State University. Serum sample results shown to be nega-
tive by HI assay and ELISA were not tested. PRNTs were
done by using WNV (strain NY99-35261-11), SLEV
(strain TBH-28), Ilhéus virus (ILHV, original strain), and
Bussuquara virus (BSQV, strain BeAn-4073). Virus stocks
were obtained from the World Health Organization Center
for Arbovirus Reference and Research, maintained at the
Centers for Disease Control and Prevention, Division of
Vector-Borne Infectious Diseases, Fort Collins, CO. We
tested serum samples for neutralizing antibodies to SLEV
because the virus is enzootic in the Americas and because
antibodies to WNV and SLEV often cross-react.
Furthermore, horses are susceptible to natural SLEV infec-
tions, although clinical manifestations have not been
reported (12). ILHV and BSQV are also present in the
Americas, although neither virus is known to naturally
infect horses (2). PRNTs were performed by using Vero
cells. Serum samples were tested by using a starting dilu-
tion of 1:20. Titers were expressed as the reciprocal of
serum dilutions yielding >90% reduction in the number of
plaques (PRNT90). 
Neutralizing antibodies to WNV were detected in three
horses (Table 3). The PRNT-positive horses were H-117,
H-126, and H-252, which exhibited PRNT90 antibody titers
of 320, >2,560, and 160, respectively. The SLEV, ILHV,
and BSQV antibody titers of the three horses were all <20.
Therefore, we considered H-117, H-126, and H-252 to be
seropositive for WNV because the PRNT90 antibodytiters
for WNV were more than fourfold higher than the other
flaviviruses tested. Overall, the PRNT and ELISA data
were in concordance; all serum samples that contained
neutralizing antibodies to WNV were positive in the assay
that used MAb 3.1112G (Tables 2 and 3). However, H-252
was negative in the assay that used MAb 6B6C-1, although
the percent inhibition value was close to the diagnostic cri-
terion. The three other horses (H-60, H-134, and H-141)
that were positive for flavivirus antibodies by HI assay or
ELISAdid not have neutralizing antibodies to WNV. H-60
had a low SLEV PRNT90 titer, suggesting it had been
infected with SLEV or a closely related virus. H-134
exhibited a HI titer of 10 but was negative by the other
serologic tests, suggesting that the HI antigen had reacted
nonspecifically. H-141 was positive by HI assay and
ELISAbut had no neutralizing antibodies to any flavivirus
tested; thus, the identity of the infecting virus was not
determined.
We obtained serologic evidence for antibodies to WNV
in Yucatan State, Mexico. The mode of entry of this virus
into Yucatan State is not known; however, the virus may
have been brought in by birds migrating from the north.
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Table 2. Summary of horses with HI assay or epitope-blocking ELISA antibodies to flaviviruses
a 
% inhibition by  
blocking ELISA
b 
Horse  Sampling date  Study site  Age (y)  Sex  Clinical symptoms  Outcome 
HI assay 
titer  3.1112G
c  6B6C-1
d 
H-60  July 2, 2002  Merida  8  Male  Gastrointestinal 
(recurrent colic) 
Survived  10  0  59 
H-117  July 5, 2002  Tizimin  7  Male  None  Survived  10  84  93 
H-126  July 5, 2002  Tizimin  2  Male  None  Survived  40  87  93 
H-134  July 5, 2002  Tizimin  3  Female  None  Survived  10  11  0 
H-141  July 5, 2002  Tizimin  10  Male  None  Survived  80  5  47 
H-252  Oct. 15, 2002  Caucel  3  Male  Neurologic and 
muscular symptoms 
Euthanized  20  64  25 
aHI, hemagglutination-inhibition; ELISA, enzyme-linked immunosorbent assay. 
bInhibition values >30% are considered significant. 
cMAb 3.1112G is WNV-specific. 
dMAb 6B6C-1 is flavivirus group–reactive. We have also detected antibodies to WNV in certain
species of migratory birds, which supports this hypothesis.
Data from the avian surveillance studies conducted in
Yucatan State will be described separately (J.A. Farfán-
Ale, unpub. data). We plan to isolate and amplify viral
sequences from migratory and resident birds, as well as
from specimens from other seropositive animals, to deter-
mine the origin of the WNV strain in Yucatan State. We
also provide serologic evidence for WNV infection in
horses in Coahuila State (13). These two reports provide
the first published evidence of WNV activity in horses in
Mexico. Neutralizing antibodies to WNV have also been
detected in a bovine in Chiapas, Mexico, in mid-2001,
indicating that the animal had been infected with WNV or
a closely related virus (14). WNV may become endemic in
this country, which demonstrates the importance for con-
tinued WNV surveillance in Mexico, and elsewhere in the
south. 
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Table 3. Neutralizing antibody titers to West Nile, Saint Louis 
encephalitis, Ilhéus, and Bussuquara viruses in serum samples 
from six horses
a 
PRNT90 titer 
Horse  WNV  SLEV  ILHV  BSQV 
H-60  –
b  20
c  –
b  – 
H-117  320  –  –
b  – 
H-126  >2,560  –
b  –  – 
H-134  –  –  –  – 
H-141  –  –  –  – 
H-252  160  –  –  – 
aWNV, West Nile virus; SLEV, Saint Louis encephalitis virus; ILHV, 
Ilhéus virus; BSQV, Bussuquara virus; PRNT, plaque reduction 
neutralization test; –, <20. 
bPRNT80 titer: 20.  
cPRNT80 titer: 40. 
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